Treatment outcomes of fixed-dose combination versus separate tablet regimens in pulmonary tuberculosis patients with or without diabetes in Qatar
Background: Tuberculosis is considered the second most common cause of death due to infectious agent. The currently preferred regimen for treatment of pulmonary tuberculosis (PTB) is isoniazid, rifampin, pyrazinamide, and ethambutol, which has been used either as separate tablets (ST) or as fixed-do...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , , , |
| التنسيق: | article |
| منشور في: |
2017
|
| الوصول للمادة أونلاين: | http://hdl.handle.net/10725/6783 http://dx.doi.org/10.1186/s12879-017-2231-1 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-017-2231-1 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|